版本:
中国

BRIEF-Quidel gets FDA clearance, CLIA waiver for Sofia 2 Immunoassay analyzer

May 30 Quidel Corp:

* Quidel receives FDA clearance and CLIA waiver for its point-of-care Sofia 2 Immunoassay analyzer for use with Sofia Influenza A+B Assay Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐